Latest Action
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
2/6/2019 • Senate
Summary
Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019
This bill generally allows the developer of a drug or biological product, such as a generic or biosimilar version of a drug, to bring a civil action against the license holder of an approved medication if the holder refuses to make available sufficient quantities of the approved medication for the developer's testing. The bill also establishes affirmative defenses to such a civil action.
In addition, the bill authorizes drug manufacturers seeking Food and Drug Administration approval for a generic drug to use alternative methods to develop elements assure safe use of a drug.Introduced in Senate • 2/5/2019
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (42)
Party Breakdown
Sponsor
Cosponsors (41)
Bill Journey
Originated in the Senate
Introduced
February 5, 2019
Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time. (Sponsor introductory remarks on measure: CR S868-869)
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law